Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study.
Liqing NingChuanyu HuPingfan LuYimei QueXiaojian ZhuDengju LiPublished in: Experimental hematology & oncology (2020)
The disease burden of CML decreased globally, especially in higher SDI countries in the past 28 years. The increasing incidence cases and death cases were mainly observed in lower SDI countries. Additionally, strategies to control modifiable risk factors such as smoking and high body mass index might be useful in diminishing mortality and DALYs.